Akbar Hedayatizadeh-Omran

10PUBLICATIONS
42CO-AUTHORS
Epidemiological methodsMolecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 22, 2025
Relationship between Anemia and Anthropometric Profile in Tabari Cohort Population: A Case-Control Study.

Ali Moghadami, Akbar Hedayatizadeh-Omran, Motahareh Kheradmand

|Jul 10, 2024
Revealing New Prospects: Antipsychotic Drugs Induces Anti-tumor Effects against Gastric Cancer through Inducing Apoptosis.

Omolbanin Amjadi, Akbar Hedayatizadeh-Omran, Ehsan Zaboli

|Jun 18, 2023
Dopamine receptors gene overexpression in the microenvironment of invasive gastric cancer and its potential implications.

Omolbanin Amjadi, Akbar Hedayatizadeh-Omran, Ehsan Zaboli

|Mar 28, 2023
Significance of Serum Apelin Levels as a Biomarker for Gastric Cancer Diagnosis.

Akbar Hedayatizadeh-Omran, Ramin Shekarriz, Omolbanin Amjadi

|Oct 29, 2022
Association between Serum Progastrin Biomarker Level and Gastric Cancer.

Omolbanin Amjadi, Reza Alizadeh-Navaei, Mahsa Rezapour

|Oct 17, 2022
The Psychometric Properties of the Fear of Progression Questionnaire (FoP-Q) for Cancer Patients in Iran.

Maryam Hasannezhad Reskati, Forouzan Elyasi, Seyed Hamzeh Hosseini

Pageof 2

Frequent Collaborators

7 joint publications

Reza Alizadeh-Navaei

4 joint publications

Ehsan Zaboli

3 joint publications

Omolbanin Amjadi

2 joint publications

Amir Shamshirian